United Therapeutics (UTHR) Tops Q3 EPS by 120c
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $544.33 +1.12%
EPS Growth %: +12.6%
Financial Fact:
Net income per basic common share (in dollars per share): 3.75
Today's EPS Names:
CBRS, MAYS, CRMT, More
EPS Growth %: +12.6%
Financial Fact:
Net income per basic common share (in dollars per share): 3.75
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q3 EPS of $3.55, $1.20 better than the analyst estimate of $2.35. Revenue for the quarter came in at $386.2 million versus the consensus estimate of $363.5 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- SPS Commerce hires Morgan Stanley to explore sale amid activist push - Reuters
- Cerebras Systems posts 94% revenue jump, announces OpenAI deal
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
